Literature DB >> 3022864

Human papillomavirus infection of the uterine cervix of women without cytological signs of neoplasia.

P G Toon, J R Arrand, L P Wilson, D S Sharp.   

Abstract

One hundred and six patients were studied whose cervical smears showed only non-specific inflammatory changes. Screening for genital pathogens yielded only a few positive cases. Histological examination of biopsy specimens taken by colposcopically directed tissue sampling showed cervical intraepithelial neoplasia in 13 of the women (12.3%). Deoxyribonucleic acid (DNA) hybridisation techniques were used to detect human papillomavirus, which was found in 24 patients (22.6%). In a second group of 104 patients with normal cervical cytology tissue biopsy samples were obtained and examined histologically but in no case was cervical intraepithelial neoplasia found. On DNA hybridisation, however, 12 patients (11.5%) were found to be positive for human papillomavirus. In this group finding human papillomavirus DNA was usually associated with a columnar ectopy. An association between human papillomavirus type 16 DNA and both cervical intraepithelial neoplasia and cervical cancer is well established. In this study it was type 16 which occurred most frequently in both groups.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3022864      PMCID: PMC1342105          DOI: 10.1136/bmj.293.6557.1261

Source DB:  PubMed          Journal:  Br Med J (Clin Res Ed)        ISSN: 0267-0623


  29 in total

1.  Some factors influencing the proliferation of the reserve cells in the human cervix.

Authors:  L M HELLMAN; A H ROSENTHAL; R W KISTNER; R GORDON
Journal:  Am J Obstet Gynecol       Date:  1954-04       Impact factor: 8.661

2.  Labeling deoxyribonucleic acid to high specific activity in vitro by nick translation with DNA polymerase I.

Authors:  P W Rigby; M Dieckmann; C Rhodes; P Berg
Journal:  J Mol Biol       Date:  1977-06-15       Impact factor: 5.469

3.  Prevalence of human papillomavirus type 16 DNA in cervical carcinoma samples in East Anglia.

Authors:  S M Scholl; E M Pillers; R E Robinson; P J Farrell
Journal:  Int J Cancer       Date:  1985-02-15       Impact factor: 7.396

4.  A rapid method for detecting and mapping homology between heterologous DNAs. Evaluation of polyomavirus genomes.

Authors:  P M Howley; M A Israel; M F Law; M A Martin
Journal:  J Biol Chem       Date:  1979-06-10       Impact factor: 5.157

5.  Characterization of a new type of human papillomavirus that causes skin warts.

Authors:  G Orth; M Favre; O Croissant
Journal:  J Virol       Date:  1977-10       Impact factor: 5.103

6.  Genital warts and cervical cancer. I. Evidence of an association between subclinical papillomavirus infection and cervical malignancy.

Authors:  R Reid; C R Stanhope; B R Herschman; E Booth; G D Phibbs; J P Smith
Journal:  Cancer       Date:  1982-07-15       Impact factor: 6.860

7.  Neoplasia of the cervix uteri and contraception: a possible adverse effect of the pill.

Authors:  M P Vessey; M Lawless; K McPherson; D Yeates
Journal:  Lancet       Date:  1983-10-22       Impact factor: 79.321

8.  Papillomavirus genomes in human cervical tumors: analysis of their transcriptional activity.

Authors:  H Lehn; P Krieg; G Sauer
Journal:  Proc Natl Acad Sci U S A       Date:  1985-08       Impact factor: 11.205

9.  The simultaneous extraction of high-molecular-weight DNA and of RNA from solid tumors.

Authors:  P Krieg; E Amtmann; G Sauer
Journal:  Anal Biochem       Date:  1983-10-15       Impact factor: 3.365

10.  Genital infections with Chlamydia trachomatis in women attending an antenatal clinic.

Authors:  P L Wood; D Hobson; E Rees
Journal:  Br J Obstet Gynaecol       Date:  1984-12
View more
  35 in total

Review 1.  Molecular techniques in the diagnosis of human infectious diseases.

Authors:  U Desselberger; K Collingham
Journal:  Genitourin Med       Date:  1990-10

2.  Detection of transcripts of human papillomaviruses 16 and 18 in cancer-derived cell lines and cervical biopsies by enzyme immunoassay for DNA-RNA hybrids following solution hybridization.

Authors:  F Coutlée; K V Shah; J S Rader; J L Currie; R P Viscidi
Journal:  J Clin Microbiol       Date:  1991-05       Impact factor: 5.948

3.  In situ human papillomavirus (HPV) genotyping of cervical intraepithelial neoplasia in South African and British patients: evidence for putative HPV integration in vivo.

Authors:  K Cooper; C S Herrington; A K Graham; M F Evans; J O McGee
Journal:  J Clin Pathol       Date:  1991-05       Impact factor: 3.411

4.  Implications of inflammatory changes on cervical cytology.

Authors:  P Oakeley; E A Davidson
Journal:  BMJ       Date:  1990-04-14

5.  Evaluation of abnormal cervical cytology results in a genitourinary clinic.

Authors:  D Hicks; V Brown; R C Spencer
Journal:  Genitourin Med       Date:  1989-10

6.  Role of human papillomavirus in determining the HLA associated risk of cervical carcinogenesis.

Authors:  W Z Mehal; Y M Lo; C S Herrington; M F Evans; M C Papadopoulos; K Odunis; T S Ganesan; J O McGee; J I Bell; K A Fleming
Journal:  J Clin Pathol       Date:  1994-12       Impact factor: 3.411

7.  Cervical papillomavirus infection and cervical dysplasia in Hispanic, Native American, and non-Hispanic white women in New Mexico.

Authors:  T M Becker; C M Wheeler; N S McGough; S W Jordan; M Dorin; J Miller
Journal:  Am J Public Health       Date:  1991-05       Impact factor: 9.308

Review 8.  A possible role for human papillomaviruses in head and neck cancer.

Authors:  B M Steinberg; T P DiLorenzo
Journal:  Cancer Metastasis Rev       Date:  1996-03       Impact factor: 9.264

9.  Comparative analysis of human papillomavirus detection by dot blot hybridisation and non-isotopic in situ hybridisation.

Authors:  G Troncone; S M Anderson; C S Herrington; M L de Angelis; H Noell; J A Chimera; J O'D McGee
Journal:  J Clin Pathol       Date:  1992-10       Impact factor: 3.411

10.  Oral contraceptive use and human papillomavirus infection in women without abnormal cytological results.

Authors:  G Veress; T Csiky-Mészáros; J Czeglédy; L Gergely
Journal:  Med Microbiol Immunol       Date:  1992       Impact factor: 3.402

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.